Virax Biolabs – Monkeypox Diagnosis and Immune Profiling Using Proprietary T cell Test Technology

Dr. Tomasz George, Ph.D., Chief Scientific Officer at Virax Biolabs, a global biotechnology company that focuses on the detection and diagnosis of viral diseases, discusses the development of a proprietary T cell testing platform – Virax Immune. As the diagnostics space moves towards more T cell-based testing, Virax expects to augment the patient/user experience by launching the Virax Immunity mobile application, which can help individuals track their immune status and provide suggestions to improve their health and lifestyle. Virax has commercially available tests for COVID-19 and recently announced the introduction of monkeypox and varicella-zoster viruses real-time PCR detection kits.

Tomasz has a Ph.D. in Applied Physiology and Ageing from King’s College London. He has 12 years of experience developing digital healthcare systems focussing on diagnostics, physiological assessments, biochemistry, and laboratory analysis. Tomasz has held the position of Chief Scientific Officer for London-based Soza Health and Singapore-based Verita Healthcare Group. He has also worked in scientific research at Imperial College London and Liverpool John Moore’s University.